T Bruin - JoVE Visualize

Showing results (21-30 of 28) with videos related to

Pageof 3

Sort By:

You have reached the last page of results.This site can display upto 28 results.

Arteriosclerosis, Thrombosis, and Vascular Biology|March 1, 1997

Ser447stop mutation in lipoprotein lipase is associated with elevated HDL cholesterol levels in normolipidemic malesJ A Kuivenhoven, B E Groenemeyer, J M Boer, et al.

The Netherlands Journal of Medicine|November 1, 1996

Compound heterozygosity for a known and a novel defect in the lipoprotein lipase gene (Asp250-->Asn; Ser251-->Cys) resulting in lipoprotein lipase (LPL) deficiencyS M Bijvoet, H Wiebusch, Y Ma, et al.

Arteriosclerosis, Thrombosis, and Vascular Biology|April 1, 1995

A common variant in the gene for lipoprotein lipase (Asp9-->Asn). Functional implications and prevalence in normal and hyperlipidemic subjectsF Mailly, Y Tugrul, P W Reymer, et al.

The Journal of Biological Chemistry|January 25, 1992

Two naturally occurring mutations at the first and second bases of codon aspartic acid 156 in the proposed catalytic triad of human lipoprotein lipase. In vivo evidence that aspartic acid 156 is essential for catalysisY H Ma, T Bruin, S Tuzgol, et al.

Human Molecular Genetics|September 1, 1995

A frequently occurring mutation in the lipoprotein lipase gene (Asn291Ser) contributes to the expression of familial combined hyperlipidemiaP W Reymer, B E Groenemeyer, E Gagné, et al.

European Journal of Biochemistry|September 1, 1992

A missense mutation Pro157 Arg in lipoprotein lipase (LPLNijmegen) resulting in loss of catalytic activityT Bruin, J J Kastelein, D E Van Diermen, et al.

Circulation|June 17, 1997

Genetic variant showing a positive interaction with beta-blocking agents with a beneficial influence on lipoprotein lipase activity, HDL cholesterol, and triglyceride levels in coronary artery disease patients. The Ser447-stop substitution in the lipoprotein lipase gene. REGRESS Study GroupB E Groenemeijer, M D Hallman, P W Reymer, et al.

Circulation|October 15, 1996

The Asp9 Asn mutation in the lipoprotein lipase gene is associated with increased progression of coronary atherosclerosis. REGRESS Study Group, Interuniversity Cardiology Institute, Utrecht, The Netherlands. Regression Growth Evaluation Statin StudyJ W Jukema, A J van Boven, B Groenemeijer, et al.

Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:

Pageof 3

You have reached the last page of results.This site can display upto 28 results.

Arteriosclerosis, Thrombosis, and Vascular Biology|March 1, 1997

Ser447stop mutation in lipoprotein lipase is associated with elevated HDL cholesterol levels in normolipidemic malesJ A Kuivenhoven, B E Groenemeyer, J M Boer, et al.

The Netherlands Journal of Medicine|November 1, 1996

Compound heterozygosity for a known and a novel defect in the lipoprotein lipase gene (Asp250-->Asn; Ser251-->Cys) resulting in lipoprotein lipase (LPL) deficiencyS M Bijvoet, H Wiebusch, Y Ma, et al.

Arteriosclerosis, Thrombosis, and Vascular Biology|April 1, 1995

A common variant in the gene for lipoprotein lipase (Asp9-->Asn). Functional implications and prevalence in normal and hyperlipidemic subjectsF Mailly, Y Tugrul, P W Reymer, et al.

The Journal of Biological Chemistry|January 25, 1992

Two naturally occurring mutations at the first and second bases of codon aspartic acid 156 in the proposed catalytic triad of human lipoprotein lipase. In vivo evidence that aspartic acid 156 is essential for catalysisY H Ma, T Bruin, S Tuzgol, et al.

Human Molecular Genetics|September 1, 1995

A frequently occurring mutation in the lipoprotein lipase gene (Asn291Ser) contributes to the expression of familial combined hyperlipidemiaP W Reymer, B E Groenemeyer, E Gagné, et al.

European Journal of Biochemistry|September 1, 1992

A missense mutation Pro157 Arg in lipoprotein lipase (LPLNijmegen) resulting in loss of catalytic activityT Bruin, J J Kastelein, D E Van Diermen, et al.

Circulation|June 17, 1997

Genetic variant showing a positive interaction with beta-blocking agents with a beneficial influence on lipoprotein lipase activity, HDL cholesterol, and triglyceride levels in coronary artery disease patients. The Ser447-stop substitution in the lipoprotein lipase gene. REGRESS Study GroupB E Groenemeijer, M D Hallman, P W Reymer, et al.

Circulation|October 15, 1996

The Asp9 Asn mutation in the lipoprotein lipase gene is associated with increased progression of coronary atherosclerosis. REGRESS Study Group, Interuniversity Cardiology Institute, Utrecht, The Netherlands. Regression Growth Evaluation Statin StudyJ W Jukema, A J van Boven, B Groenemeijer, et al.

Pageof 3